You searched for - Page 199 of 766

KHN’s ‘What the Health?’: Delta Changes the Covid Conversation

With covid cases on the upswing again around the country, partisan division remains over how to address the pandemic. Meanwhile, the Biden administration proposes bigger penalties for hospitals that fail to make their prices public as required. Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Tami Luhby of CNN join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite stories of the week they think you should read, too.

July 22, 2021

COVID-19

Big Leagues Balk at Endorsing Vaccination

The major sports leagues are struggling to vaccinate enough of their players to protect the clubhouse and locker room, and few stars have stepped forward to pitch vaccination to teammates or fans. WNBA players are an exception, with a 99% vaccination rate and high-profile ads urging the public to get vaccinated.

By Mark Kreidler

July 22, 2021

Wildfire Smoke Drives People in Low-Vaccinated Areas Indoors, Raising Outbreak Fears

Unvaccinated Westerners are flocking to movie theaters, malls and other indoor spaces to beat the smoke and heat. Health officials worry that may fuel covid outbreaks.

By Aaron Bolton, MTPR

July 22, 2021

A Chilling Cure: Facing Killer Heat, ERs Use Body Bags to Save Lives

Doctors in Washington state used human body bags filled with ice and water to rapidly cool the sickest patients affected by record heat last month.

By JoNel Aleccia

July 22, 2021

COVID-19

The Delta Variant Thrives in a State of Political and Public Health Discord

At the center of the nation’s delta variant outbreak, public health efforts are mired in a political turf war.

By Lauren Weber

July 21, 2021

COVID-19

Analysis: Necessary or Not, Covid Booster Shots Are Probably on the Horizon

In today’s pharmaceutical universe, a simple “safe and effective” determination by the Food and Drug Administration to approve a drug can be manipulated to sell products of questionable value. And drugmakers can profit handsomely.

By Elisabeth Rosenthal

July 21, 2021

Though Millions Are at Risk for Diabetes, Medicare Struggles to Expand Prevention Program

Medicare has proposed revamping its payment rules to get more people into a diabetes prevention plan that helps them eat better, exercise more and maintain a healthier lifestyle. Out of an estimated 16 million Medicare beneficiaries whose excess weight and other risk factors make them eligible, only 3,600 have participated since 2018.

By Harris Meyer

July 21, 2021

With a Diagnosis at Last, Black Women with ADHD Start Healing

Black women and girls with attention deficit hyperactivity disorder often remain undiagnosed because their symptoms are mischaracterized by the blinders of sexism and racism. Getting treatment and finding the right medication can be even more difficult because they aren’t taken seriously or, worse, they’re racially profiled while getting their medicines.

By Claire Sibonney

July 20, 2021

Sen. Wyden: $3.5T Budget May Have to Trim but It Can Set a Path to ‘Ambitious Goals’

Sen. Ron Wyden (D-Ore.), who is helping to negotiate the health care spending framework for the Democrats' budget plan, said lawmakers may have to settle for very basic versions of programs deployed in the package. But the key, he added, is to get the "architecture of these changes, bold changes," started and show people what is possible.

By Michael McAuliff

July 20, 2021

State Capitol Building, Sacramento, California

California Makes It Easier for Low-Income Residents to Get and Keep Free Health Coverage

State lawmakers aim to expand Medicaid enrollment by dedicating billions of dollars in coming years to simplifying paperwork, extending pregnancy coverage and opening the program to thousands of new enrollees, including older unauthorized immigrants and people who need nursing home care.

By Rachel Bluth

July 20, 2021

Novavax’s Effort to Vaccinate the World, From Zero to Not Quite Warp Speed

Novavax is a vaccine company that, despite $2 billion in new federal and international funding, still hasn't come through with a licensed covid vaccine. It hopes it can still help to fight the global covid scourge, but will it deliver?

By Sarah Jane Tribble and Rachana Pradhan

July 19, 2021

Biden Promise Tracker

Biden’s July Executive Order Includes Drug Pricing Provisions. But Will They Do Enough?

The July 9 directive addresses the importation of prescription drugs and broader efforts to reduce the high cost of medicines.

By Victoria Knight

July 19, 2021

Postcard From Sacramento

Grab Your Mask and Notepad, We’re Headed Back to California’s State Capitol

After being mostly closed to the public and the press for more than a year, California’s state Capitol is open again — masks, temperature checks, covid outbreaks and all.

By Rachel Bluth

July 19, 2021

KHN On Air

Journalists’ Topics Range From Rural Pharmacy Deserts to Opioid Overdoses

KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.

July 17, 2021

Still Cashing In

Hospital ‘Trauma Centers’ Charge Enormous Fees to Treat Minor Injuries and Send People Home

Only severely injured patients are supposed to be billed for “trauma team alert” fees that can exceed $50,000.

By Jay Hancock

July 16, 2021

Fútbol, Flags and Fun: Getting Creative to Reach Unvaccinated Latinos in Colorado

A vaccine clinic came to an international soccer tournament in Denver recently. It was an attempt to reach Latino Coloradans, whose vaccination rates trail those of non-Hispanic whites.

By John Daley, Colorado Public Radio

July 16, 2021

Podcast

KHN’s ‘What the Health?’: Here Comes Reconciliation

Democrats in Congress reached a tentative agreement to press ahead on a partisan bill that would dramatically expand health benefits for people on Medicare, those who buy their own insurance and individuals who have been shut out of coverage in states that didn’t expand Medicaid. Meanwhile, controversy continues to rage over whether vaccinated Americans will need a booster to protect against covid-19 variants, and who will pay for a new drug to treat Alzheimer’s disease. Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews KHN’s Rae Ellen Bichell, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a mother and daughter who fought an enormous emergency room bill.

July 15, 2021

Bill of the Month

How ERs Fail Patients With Addiction: One Patient’s Tragic Death

Two intractable failings of the U.S. health care system — addiction treatment and medical costs — come to a head in the ER, where patients desperate for addiction treatment arrive, only to find the facility may not be equipped to deal with substance use or, if they are, treatment is prohibitively expensive.

By Aneri Pattani

July 15, 2021

Senate Democrats’ Plan Boosts Spending on Medicare, ACA Subsidies, Long-Term Care

The plan from high-wire negotiations would affect five key areas of health, but there will be further tense negotiations among Democratic lawmakers about specifics of the $3.5 trillion in funding. And all Senate Democrats will need to be behind the plan, because Republicans oppose it.

By Michael McAuliff

July 15, 2021

Influx of Medical School Students Could Overwhelm Montana Resources, Program Leaders Warn

Leaders of a regional medical school program in Montana say two proposed medical schools could create a flood of students they worry will strain the clinical faculty and resources in the state they use for training.

By Andrea Halland

July 15, 2021

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Search

Filter